Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 25, 2010
Reporting Period: The filing announces financial results for the three months and the full year ended December 31, 2009.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K document.
Material Changes
The filing text does not provide specific data regarding material changes versus prior comparable periods. The document serves solely as a notification that results for the period ended December 31, 2009, have been issued.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on February 25, 2010, detailing the financial results.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the three months and year ended December 31, 2009.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any forward-looking statements or guidance included in the press release that are not present in this 8-K summary.
- Confirm the status of the Company's liquidity and debt obligations as detailed in the full financial results.